Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report)’s share price hit a new 52-week low on Friday . The stock traded as low as $26.11 and last traded at $26.28, with a volume of 666346 shares. The stock had previously closed at $26.96.
Analysts Set New Price Targets
Separately, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 24th.
Read Our Latest Stock Analysis on Option Care Health
Option Care Health Stock Performance
Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business’s revenue was up 12.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.21 EPS. On average, research analysts forecast that Option Care Health, Inc. will post 1.19 EPS for the current fiscal year.
Institutional Trading of Option Care Health
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Park Place Capital Corp raised its position in Option Care Health by 48.4% in the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after purchasing an additional 372 shares during the period. Parallel Advisors LLC grew its stake in Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 478 shares in the last quarter. Principal Securities Inc. bought a new position in Option Care Health in the 4th quarter worth about $27,000. Envestnet Portfolio Solutions Inc. grew its stake in Option Care Health by 14.5% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 6,798 shares of the company’s stock worth $228,000 after acquiring an additional 861 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Option Care Health by 11.0% during the third quarter. Tower Research Capital LLC TRC now owns 9,190 shares of the company’s stock valued at $297,000 after purchasing an additional 913 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- Profitably Trade Stocks at 52-Week Highs
- Qualcomm Stock Continues to Rise in the Face of Negative News
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Top 3 Summer Stocks with Solid Growth Opportunities
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.